Carregant...

Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment

a. agents which reduce or prevent sickle cell dehydration; b. agents which reduce sickle cell-endothelial adhesive events; c. nitric oxide (NO) or NO-related compounds; d. anti-oxidant agents. Correction of the abnormalities ranging from membrane cation transport pathways to red cell-endothelial adh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: De Franceschi, Lucia
Format: Artigo
Idioma:Inglês
Publicat: Università Cattolica del Sacro Cuore 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3033152/
https://ncbi.nlm.nih.gov/pubmed/21415994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2009.024
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!